Show simple item record

dc.contributor.authorAckermann, Christoph J
dc.contributor.authorFornacon-Wood, I
dc.contributor.authorTay, Rebecca
dc.contributor.authorManoharan, Prakash
dc.contributor.authorPrice, Gareth J
dc.contributor.authorLindsay, Colin R
dc.contributor.authorFaivre-Finn, Corinne
dc.contributor.authorBlackhall, Fiona H
dc.contributor.authorCobben, David
dc.date.accessioned2019-12-09T17:08:13Z
dc.date.available2019-12-09T17:08:13Z
dc.date.issued2019en
dc.identifier.citationAckermann C, Fornacon-Wood I, Tay R, Manoharan P, Price G, Lindsay C, et al. P1.04-44 Radiomics for Predicting Response to First-Line Anti-PD1 Therapy in Advanced NSCLC. Journal of Thoracic Oncology. 2019;14(10):S457-S8.en
dc.identifier.doi10.1016/j.jtho.2019.08.947en
dc.identifier.urihttp://hdl.handle.net/10541/622524
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1016/j.jtho.2019.08.947en
dc.titleRadiomics for predicting response to first-line anti-PD1 therapy in advanced NSCLCen
dc.typeMeetings and Proceedingsen
dc.contributor.departmentMedical Oncology, The Christie NHS Foundation Trust, Manchester/GBen
dc.identifier.journalJournal of Thoracic Oncologyen
dc.description.noteen


Files in this item

This item appears in the following Collection(s)

Show simple item record